A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
In a recent study published in Scientific Reports, researchers investigated the performance of a machine learning (ML)-based model in evaluating radiomic features to diagnose coronary artery disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results